Mobile Health App for High Blood Pressure
Trial Summary
What is the purpose of this trial?
The purpose of this study is to test the proof-of-concept for adding a novel mHealth application, USeeBP, to the established UChicago Medicine Ambulatory Medicine Remote-Patient Monitoring (UCM-RPM) Hypertension Management Program in a population of African American adults with poorly controlled hypertension.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current treatment, but it's best to confirm with the study team.
What data supports the effectiveness of the treatment USeeBP for high blood pressure?
Research shows that mobile health apps can help people manage high blood pressure by improving medication adherence and encouraging lifestyle changes. Apps that combine blood pressure monitoring with feedback and education have been shown to help reduce blood pressure and improve how well people stick to their treatment plans.12345
Is the Mobile Health App for High Blood Pressure safe for humans?
How does the mobile health app treatment for high blood pressure differ from other treatments?
This mobile health app treatment is unique because it uses smartphone technology to help patients monitor their blood pressure at home, potentially improving medication adherence and lifestyle changes. Unlike traditional treatments, it offers a convenient way to track and manage blood pressure through self-measurement and digital engagement, which may be particularly appealing to younger users.135910
Research Team
David G. Beiser, MD
Principal Investigator
University of Chicago
Eligibility Criteria
This trial is for African American adults aged 18-65 with high blood pressure (SBP ≥ 160 mmHg). Participants must have access to an iPhone, Wi-Fi or data plan, and be able to use the USeeBP app and a wireless blood pressure cuff. They should not be homeless, recently hospitalized for psychiatric reasons, pregnant, prisoners, opioid-dependent or have certain severe medical conditions.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the USeeBP mHealth app alongside the UCM-RPM program to monitor and manage blood pressure
Follow-up
Participants are monitored for changes in blood pressure control and medication adherence
Treatment Details
Interventions
- USeeBP (Behavioural Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
Pete Salzmann
University of Chicago
Chief Executive Officer since 2018
MD from University of Chicago’s Pritzker School of Medicine, MBA from Stanford University’s Graduate School of Business
Anh Nguyen
University of Chicago
Chief Medical Officer
MD from Rutgers New Jersey Medical School, MBA from University of Chicago